A phase II study of the insulin-like growth factor type I receptor inhibitor IMC-A12 in patients with metastatic uveal melanoma

Published 2020 View Full Article

Authors

Keywords

Journal

MELANOMA RESEARCH

Volume Publish Ahead of Print, Issue -, Pages -

Publisher

Ovid Technologies (Wolters Kluwer Health)

Online

2020-09-25

DOI

10.1097/cmr.0000000000000694

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

MELANOMA RESEARCH

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Publish scientific posters with Peeref

Ask a Question. Answer a Question.